![]() |
|
|
Vol. 298, Issue 1, 288-297, July 2001
Curriculum in Neurobiology (R.M.A., L.A.D.), Departments of
Psychology and Pharmacology (L.A.D.), University of North Carolina at
Chapel Hill, Chapel Hill, North Carolina
Data from rodent antinociception models indicate that
N-methyl-D-aspartate (NMDA) receptor
antagonists do not produce antinociception alone or potentiate morphine
antinociception, but do attenuate the development of morphine
tolerance. This study examined the antinociceptive effects of the
noncompetitive NMDA receptor antagonist dizocilpine, the competitive
NMDA receptor antagonist
(
)-6-phosphonomethyl-decahydroisoquinoline-3-carboxylic acid
(LY235959), and the glycine-site antagonist
(+)-(1-hydroxy-3-aminopyrrolidine-2-one) [(+)-HA-966], alone and in
combination with morphine in a squirrel monkey titration procedure. In
this procedure, shock (delivered to the tail) increased in intensity
every 15 s from 0.01 to 2.0 mA in 30 increments. Five lever
presses during any given 15-s shock period produced a 15-s shock-free
period after which shock resumed at the next lower intensity. Morphine
(0.3-3.0 mg/kg i.m.) dose-dependently increased the intensity below
which monkeys maintained shock 50% of the time (median shock level;
MSL). In contrast, dizocilpine (0.003-0.1 mg/kg i.m.) produced only
modest increases in MSL in some monkeys (three of five) at the highest
dose tested. Neither LY235959 (0.1-1.0 mg/kg i.m.) or (+)-HA-966
(10-56 mg/kg i.m.) increased MSL in any monkey tested. Dizocilpine,
LY235959, and (+)-HA-966, when administered in combination with doses
of morphine (1.0 mg/kg, 1.7 mg/kg) that either produced no
antinociception or produced very little antinociception, were all found
to dose-dependently potentiate the antinociceptive effect of morphine.
Importantly, although these NMDA antagonists in combination with
morphine produced marked increases in MSL, these combinations did not
alter response rate, demonstrating that the potentiation was not due to
nonspecific motor effects.
This article has been cited by other articles:
![]() |
R. M. Allen, A. L. Granger, and L. A. Dykstra The Competitive N-Methyl-D-aspartate Receptor Antagonist (-)-6-Phosphonomethyl-deca-hydroisoquinoline-3-carboxylic Acid (LY235959) Potentiates the Antinociceptive Effects of Opioids That Vary in Efficacy at the {micro}-Opioid Receptor J. Pharmacol. Exp. Ther., November 1, 2003; 307(2): 785 - 792. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. M. Allen, A. L. Granger, and L. A. Dykstra Dextromethorphan Potentiates the Antinociceptive Effects of Morphine and the delta -Opioid Agonist SNC80 in Squirrel Monkeys J. Pharmacol. Exp. Ther., February 1, 2002; 300(2): 435 - 441. [Abstract] [Full Text] [PDF] |
||||